B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up.
作者信息
Brown J A, Stone M M, Sutherland I
出版信息
Br Med J. 1968 Jan 6;1(5583):24-7. doi: 10.1136/bmj.1.5583.24.
Abstract
摘要
相似文献
1
B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up.
Br Med J. 1968 Jan 6;1(5583):24-7. doi: 10.1136/bmj.1.5583.24.
2
Biology of the mycobacterioses. Studies of BCG vaccination against leprosy in Uganda.
Ann N Y Acad Sci. 1968 Sep 5;154(1):237-43. doi: 10.1111/j.1749-6632.1968.tb16712.x.
3
B.C.G. vaccination of children against leprosy: first results of a trial in Uganda.
Br Med J. 1966 Jan 1;1(5478):7-14. doi: 10.1136/bmj.1.5478.7.
4
BCG vaccination of children against leprosy in Uganda: final results.
J Hyg (Lond). 1981 Oct;87(2):233-48. doi: 10.1017/s002217240006945x.
5
[Contribution to the study of leprosy and BCG vaccination among the children of lepers and non-family contacts in Iran].
Acta Leprol. 1984 Jan-Mar;2(1):39-45.
6
Trial of BCG vaccination against leprosy in Uganda.
Lepr Rev. 1969 Jan;40(1):3-7. doi: 10.5935/0305-7518.19690003.
7
BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma.
Bull World Health Organ. 1985;63(6):1069-78.
8
BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.
Bull World Health Organ. 1974;51(1):93-9.
9
A TRIAL OF BCG VACCINATION IN THE PROPHYLAXIS OF LEPROSY.
Lepr Rev. 1963 Jul;34:118-22. doi: 10.5935/0305-7518.19630019.
10
BCG vaccination in mycobacterial infections.
Br Med Bull. 1969 May;25(2):183-8. doi: 10.1093/oxfordjournals.bmb.a070690.
引用本文的文献
1
Bacillus of Calmette and Guérin (BCG) and the risk of leprosy in Ciudad del Este, Paraguay, 2016-2017.
Epidemiol Health. 2021;43:e2021060. doi: 10.4178/epih.e2021060. Epub 2021 Sep 8.
2
Leprosy.
BMJ Clin Evid. 2007 Apr 1;2007:0915.
3
BCG vaccination of children against leprosy in Uganda: final results.
J Hyg (Lond). 1981 Oct;87(2):233-48. doi: 10.1017/s002217240006945x.
4
Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.
Infect Immun. 1980 Jun;28(3):860-6. doi: 10.1128/iai.28.3.860-866.1980.
5
Sensitization or tolerance to Mycobacterium leprae antigen by route of injection.
Infect Immun. 1982 Nov;38(2):673-80. doi: 10.1128/iai.38.2.673-680.1982.
6
Treatment of leprosy in the United States.
Bull N Y Acad Med. 1984 Sep;60(7):696-711.
7
Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.
Infect Immun. 1983 Jun;40(3):1096-103. doi: 10.1128/iai.40.3.1096-1103.1983.
8
9
Some recent laboratory findings on Mycobacterium leprae. Implications for the therapy, epidemiology and control of leprosy.
Bull World Health Organ. 1970;43(4):559-69.
10
New prospects for the study of leprosy in the laboratory.
Bull World Health Organ. 1969;40(5):785-800.
本文引用的文献
1
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
Am Rev Respir Dis. 1966 Oct;94(4):553-68. doi: 10.1164/arrd.1966.94.4.553.
Zotero 插件